Mon, December 5, 2022

Sean Lee Initiated (AKTX) at Strong Buy and Held Target at $30 on, Dec 5th, 2022

Sean Lee of HC Wainwright & Co., Initiated "Akari Therapeutics, Plc" (AKTX) at Strong Buy and Held Target at $30 on, Dec 5th, 2022.

Sean has made no other calls on AKTX in the last 4 months.



There is 1 other peer that has a rating on AKTX. Out of the 1 peers that are also analyzing AKTX, 0 agree with Sean's Rating of Hold.



This is the rating of the analyst that currently disagrees with Sean


  • James Molloy of "Alliance Global Partners" Initiated at Strong Buy and Held Target at $80 on, Tuesday, November 1st, 2022